Children's Hospital, Goethe-University
Frankfurt am Main, Hesse, 60590, Germany
NCT Number: NCT01327248
The aim of this case-control study is the characterization of the bronchial and systemic inflammation of children and young adults with bronchiolitis obliterans.
On the first visit subjects are asked to perform a lung function test (spirometry, body plethysmography with helium). Further levels of eNO and eCO are determined. A blood sample is drawn to describe the inflammatory status. Bronchial inflammation will be measured in induced sputum. At the second visit, a non-specific bronchial provocation testing (PD20 FEV1 methacholine) is performed.
Looking for future studies?
Notify Me6 year–25 year
All sexes
Observational
Frankfurt am Main, Hesse, 60590, Germany
Objectives:
The aim of this study is the characterization of patients with bronchiolitis obliterans in terms of lung function, bronchial hyperreactivity and the degree of the systemic and bronchial inflammation.
Sputum and serum samples are analyzed by quantitative real-time polymerase chain reaction (PCR) (qRT-PCR) and by cytometric bead assay (CBA). Components of the innate immune system (mannose-binding protein, TLR recognition proteins and surfactant proteins) are genetically determined from sputum or blood respectively. In the conduct of this study the investigators will retrospectively and systematically evaluate the available high-resolution computed tomography (HRCT) studies of affected patients
Methods and Work Programme:
This study consists of two study visits (V1 and V2)
V1:
V2:
Study population:
Children and young people (6 - 25 years of age). Both the patients and the healthy subjects are recruited from the outpatient clinic of Pediatric Allergy and Pulmonology.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Johann Wolfgang Goethe University Hospital
Other
Acronym: Frabo
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02495597
Bronchial Diseases, Bronchiolitis
Frankfurt am Main, Hesse, Germany
View Trial DetailsNCT01633385
Bronchial Diseases, Bronchiolitis
Frankfurt am Main, Hesse, Germany
View Trial DetailsNCT04080232
Bronchial Diseases, Bronchiolitis
Bordeaux, France
View Trial DetailsNCT03656926
Behavior, Bronchial Diseases
Phoenix, Arizona, United States
View Trial Details